Plenary presentation
9
ON THE PHARMACOLOGICAL ACTIVITY AND PROSPECTS FOR THE
PRACTICAL USE OF 1-ARYL-1,2,3,4-TETRAHYDROISOQUINOLINES
F.M.Tursunkhodjaeva, A.A.Azamatov, Sh.N.Zhurakulov, V.I.Vinogradova
Institute of Chemistry of Plant Substances, Academy of Sciences of the Republic of
Uzbekistan, Tashkent, ftm40438@gmail.com
The 1,2,3,4-tetrahydroisoquinoline (THIQ) derivatives have been reported to
possess a wide range of pharmacological activities like anti-inflammatory, anti-
bacterial,
anti-viral, anti-fungal, anti-leishmanial,
anti-cancer, anti-malarial, anti-
Alzheimer,
antiparkinsonian,
antidepressant,
anticonvulsant,
antiarrhythmic,
hypotensive and hypertensive, and inhibiting NO production. Some of the THIQ
analogs are used clinically: Praziquantel (antihelmintic), Quinapril (antihypertensive),
Apomorphine (Antiparkinsonian), Tubocurarine (skeletal muscle relaxant), Trabectedin
(anticancer) and others.
We have investigated 1-aryl-1,2.3.4-THIQ derivatives
synthesized at the
Institute of the Chemistry of Plant Substances, Uzbekistan. Among 32 studied
substances we have identified potent substances
with local-anesthetic, analgesic, anti-
inflammatory,
antiarrhythmic,
antihypoxic,
psychotropic,
antioxidant
and
anticonvulsant activity.
Structure-toxicity and structure-activity relations were analyzed.
Dostları ilə paylaş: